DLA Piper has welcomed Joshua A. Kaufman as co-chair of Capital Markets and Public Company Advisory Practice based out of the firm’s New York and Miami offices.
Kaufman is a commercially oriented corporate counselor who advises high-growth businesses on financing pathways, strategic development, and transformational transactions. He is well-versed in cross-border matters, having advised leading innovative companies in the United Kingdom, the Nordics, Continental Europe, and Israel.
Kaufman also represents US and foreign private issuers and underwriters in various public offerings and private placements, primarily in the life sciences and technology sectors. He has advised on over 200 financing transactions with an aggregate value of over $100 billion. And he frequently represents clients before the Securities and Exchange Commission, and advises on corporate governance, general corporate and commercial matters.
Kaufman’s notable experience includes representing underwriting syndicates in the first dual listings of Danish and Swedish companies in the US, a New York biotech in its $40 million IPO and numerous follow-on offerings, a national restaurant chain in its US$140 million primary and US$75 million at-the-market offerings, a UK-listed biotech in its transition to Nasdaq and numerous follow-on offerings, as well as four IPOs out of Israel aggregating $1.2 billion.
KEY QUOTES:
“Josh’s strong cross-border practice and vast knowledge of the increasingly complex transactional landscape, especially in rapidly growing sectors like life sciences and technology, will further invigorate the positive momentum of our capital market practice. His experience and leadership will be strong assets for our team and our clients, and we’re eager to have him on board.”
- Era Anagnosti, co-chair of DLA Piper’s Capital Markets and Public Company Advisory practice
“We are actively expanding our capital markets, M&A and venture capital capabilities in the life sciences and technology sectors, and we are confident that Josh will provide a significant addition to our strong capital markets team in these key sectors.”
- Andy Gilbert, DLA Piper’s chair of the US Corporate practice
